Hypertension Diagnostics to Present 
at August 14 Bluefire Research Investor Conference

Presentation to Investors Will be Simultaneously Webcast

ST. PAUL, MNAugust 10, 2001 Hypertension Diagnostics, Inc. (Nasdaq SmallCap: HDII; HDIIW; HDIIU; HDIIZ), developer of proprietary cardiovascular profiling systems for clinical and research applications, said today that it will be a presenting company at the upcoming BlueFire Research Investor Conference to be held beginning at 3:00 p.m. on Tuesday, August 14, 2001, at the Minneapolis Hilton located at 1001 Marquette Avenue in Minneapolis, MN.

 

   
Greg Guettler, President of HDI, will present to investors current Company developments and HDI’s business strategy, including information on the Company’s proprietary CVProfilor
ä DO-2020 CardioVascular Profiling System.  The presentation will also be broadcast live over the Internet. To listen to the conference, log on to the Bluefire website at www.bluefireresearch.com and follow the links on the day of the event.  To attend the conference, call 612-344-1032 or RSVP online at www.bluefirepartners.com.

About Hypertension Diagnostics

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for clinical and research applications.  These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world.  In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s blood pressure waveform analysis technology.  The system includes a custom designed Arterial PulseWave™ Sensor to capture waveform data as well as a printer which generates a CVProfile™ Report which can assist physicians in their clinical work.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company's 2000 Annual Report on Form 10-KSB, as amended, under the caption “Risk Factors,'' as well as others not now anticipated.

About BlueFire Research

BlueFire Research is an SEC Registered Investment Advisor.  It is a subsidiary of BlueFire Partners, Inc, a research driven and relationship oriented boutique capital markets firm based in Minneapolis , with an additional office in New York City .  BlueFire Research provides research coverage and prepares reports and periodic updates to investment professionals, made available to more than 2,000 institutional money management firms, representing 30,000 portfolio managers and buy-side analysts, through Thompson Financial’s First Call Direct®. 

Hypertension Diagnostics, HDI/PulseWave™ and CVProfilor® are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Contact: Greg H. Guettler, President

Return to the Main HDI Newsroom

   

Back to Top

 

 

     

Copyright © 2010 Hypertension Diagnostics, Inc
Last revised Wednesday June 23, 2010
HDI Legal Information